Bio Key International BKYI Estimates

NASDAQ BKYI
$2.77 +0.11 (+4.13%)
As of: Sep 9, 2026 · 3:31 PM EDT
Analyst Estimates

Bio Key International Inc Revenue Estimates

Periods 18
Next Period Q3 26
Consensus 2.27 M

Analysts expect Bio Key International Inc to report revenue of 2.27 M for Q3 26, against a range of 2.20 M to 2.34 M. The most recent reported quarter, Q2 26, came in at 1.92 M, a 10.8% beat against the 1.73 M consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) 2.14 M1.46 M1.61 M1.70 M1.55 M1.24 M2.15 M1.92 M--------
High Estimate 2.23 M2.51 M1.33 M1.76 M2.00 M2.54 M2.38 M1.82 M2.34 M3.02 M3.09 M3.17 M3.25 M3.43 M4.60 M4.59 M
Low Estimate 1.91 M2.30 M1.17 M1.49 M1.78 M2.12 M2.21 M1.65 M2.20 M2.73 M2.81 M2.84 M2.95 M2.89 M3.86 M3.98 M
Consensus Estimate 2.07 M2.41 M1.25 M1.63 M1.89 M2.33 M2.30 M1.73 M2.27 M2.88 M2.95 M3.01 M3.10 M3.16 M4.23 M4.28 M
Analyst Estimates

Bio Key International Inc Earnings Per Share (EPS) Estimates

Periods 18
Next Period Q3 26
Consensus -0.36

Analysts expect Bio Key International Inc to report earnings per share of -0.36 for Q3 26, against a range of -0.38 to -0.34. The most recent reported quarter, Q2 26, came in at -0.56, a 28.2% beat against the -0.78 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) -3.90-5.30-1.60-2.00-1.50-1.90-0.15-0.56--------
High Estimate -3.49-2.99-2.14-1.46-1.07-0.72-0.52-0.76-0.34-0.230.280.200.630.661.851.52
Low Estimate -3.89-3.57-2.40-1.70-1.27-0.78-0.64-0.80-0.38-0.270.240.160.550.561.731.28
Consensus Estimate -3.69-3.28-2.27-1.58-1.17-0.75-0.58-0.78-0.36-0.250.260.180.590.611.791.40